Data / Form D filings / DSIpharma, Inc.
DSIpharma, Inc.: Form D filing
DSIpharma, Inc., a health care company in Wilmington, DE, filed a Form D with the SEC in 2026. The latest, on October 2, 2026, reports $951,250 sold of a $3 million offering to 18 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 251 LITTLE FALLS DRIVE, Wilmington, DE, 19808
- Phone
- (866) 403-5272
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2025
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2076369
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 2 | Amendment | $3,000,000 | $951,250 | $2,048,750 | 18 | Jun 17 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Mark Ridall | Executive Officer, Director | |
| Kysha Ayana Pierre-Louis | Executive Officer, Director |
Other health care companies in Delaware that filed recently
- Hygia Technologies, Inc. $125,000 · Oct 13
- Vantage Health, Inc. $2.5 million · Oct 2
Every Form D from the week of Sep 28 · All recent filings in Delaware · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what DSIpharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.